{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:02:30Z","timestamp":1789174950920,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To estimate the global prevalence of genetic carriers of pheochromocytoma-paraganglioma syndromes (PPGLs) in a large multiethnic genomic database.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed sequencing data from 807 162 unrelated individuals in the gnomAD v4.1 database, representing a global population of diverse ethnic ancestries. Eleven PPGLs-associated genes were examined: FH, NF1, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, VHL, and MAX. Pathogenic or likely pathogenic variants (P\/LP) were identified from ClinVar, while additional predicted deleterious variants were included based on loss-of-function annotations and splice prediction in silico tools. Prevalence estimates of genetic carriers were calculated by combining allele frequencies of qualifying variants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The prevalence of SDHA carriers was the highest when aggregating allele frequencies of both ClinVar P\/LP and predicted deleterious variants (158.83 per 100 000), followed by NF1 (93.66 per 100 000) and FH (72.23 per 100 000), while VHL and MAX had the lowest prevalence. Substantial variation was observed across ancestries, with certain variants enriched in specific populations (eg, SDHC p.Tyr126Cys in non-Finnish Europeans; FH c.556-4A &amp;gt; G in East Asians). Carriers of SDHB, SDHC, and TMEM127 ClinVar P\/LP or predicted deleterious variants were absent in the Middle Eastern group; SDHAF2 and SDHC were absent in the Ashkenazi Jewish group; and SDHAF2 and TMEM127 were absent in the Finnish group. Predicted deleterious variants significantly increased carrier estimates for SDHAF2, SDHD, and TMEM127.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our study highlights the variability in PPGL-associated mutation carrier prevalence across genes and ancestries. The findings underscore potential disparities in genetic risk that may not have been fully captured by clinical cohorts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf191","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:35:26Z","timestamp":1758350126000},"page":"412-420","source":"Crossref","is-referenced-by-count":4,"title":["Estimated global prevalence of genetic carriers of hereditary pheochromocytoma-paraganglioma syndrome in a large multiethnic genomic database"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6501-6180","authenticated-orcid":false,"given":"Nipith","family":"Charoenngam","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok 10700 ,","place":["Thailand"]},{"name":"Division of Endocrinology, Massachusetts General Hospital, Harvard Medical School , Boston, MA 02114 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taweesak","family":"Wannachalee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok 10700 ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"issue":"1","key":"2025100800214490200_lvaf191-B1","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/EO-22-0044","article-title":"Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes","volume":"2","author":"Turin","year":"2022","journal-title":"Endocr Oncol"},{"issue":"6","key":"2025100800214490200_lvaf191-B2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann Hartmut","year":"2019","journal-title":"N Engl J Med."},{"issue":"2","key":"2025100800214490200_lvaf191-B3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev."},{"issue":"2","key":"2025100800214490200_lvaf191-B4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/joim.12869","article-title":"Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma","volume":"285","author":"Muth","year":"2019","journal-title":"J Intern Med."},{"issue":"6","key":"2025100800214490200_lvaf191-B5","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.beem.2024.101928","article-title":"Recent discoveries of Sino-Caucasian differences in the genetics of phaeochromocytomas and paragangliomas","volume":"38","author":"Jiang","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"6","key":"2025100800214490200_lvaf191-B6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","article-title":"Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study","volume":"15","author":"Castinetti","year":"2014","journal-title":"Lancet Oncol."},{"issue":"7","key":"2025100800214490200_lvaf191-B7","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1210\/jc.2006-2833","article-title":"Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1","volume":"92","author":"Bausch","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2025100800214490200_lvaf191-B8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncol"},{"issue":"19","key":"2025100800214490200_lvaf191-B9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann Hartmut","year":"2002","journal-title":"N Engl J Med."},{"issue":"7809","key":"2025100800214490200_lvaf191-B10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"2025100800214490200_lvaf191-B11"},{"issue":"D1","key":"2025100800214490200_lvaf191-B12","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2025100800214490200_lvaf191-B13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"1","key":"2025100800214490200_lvaf191-B14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13059-022-02664-4","article-title":"Predicting RNA splicing from DNA sequence using Pangolin","volume":"23","author":"Zeng","year":"2022","journal-title":"Genome Biol."},{"issue":"11","key":"2025100800214490200_lvaf191-B15","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/s41436-021-01265-z","article-title":"Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes","volume":"23","author":"Cubuk","year":"2021","journal-title":"Genet Med"},{"issue":"1","key":"2025100800214490200_lvaf191-B16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2350-9-20","article-title":"The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency","volume":"9","author":"Bayley","year":"2008","journal-title":"BMC Med Genet"},{"issue":"8","key":"2025100800214490200_lvaf191-B17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00383-015-3731-y","article-title":"RET gene is a major risk factor for Hirschsprung's disease: a meta-analysis","volume":"31","author":"Tomuschat","year":"2015","journal-title":"Pediatr Surg Int."},{"issue":"12","key":"2025100800214490200_lvaf191-B18","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"CONSENSUS: guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2025100800214490200_lvaf191-B19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1210\/js.2018-00120","article-title":"Pathogenicity and penetrance of germline SDHA variants in pheochromocytoma and paraganglioma (PPGL)","volume":"2","author":"Maniam","year":"2018","journal-title":"J Endocr Soc"},{"issue":"2","key":"2025100800214490200_lvaf191-B20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/jmedgenet-2021-108355","article-title":"UK recommendations for SDHA germline genetic testing and surveillance in clinical practice","volume":"60","author":"Hanson","year":"2023","journal-title":"J Med Genet"},{"issue":"3","key":"2025100800214490200_lvaf191-B21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beem.2010.04.001","article-title":"SDH-related pheochromocytoma and paraganglioma","volume":"24","author":"Kantorovich","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"2025100800214490200_lvaf191-B22","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2025100800214490200_lvaf191-B23","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1210\/js.2017-00330","article-title":"Utility of population-level DNA sequence data in the diagnosis of hereditary endocrine disease","volume":"1","author":"Newey","year":"2017","journal-title":"J Endocr Soc"},{"issue":"1","key":"2025100800214490200_lvaf191-B24","doi-asserted-by":"publisher","first-page":"e220091","DOI":"10.1530\/EO-22-0091","article-title":"Germline genetic variants in pheochromocytoma\/paraganglioma: single-center experience","volume":"3","author":"Lima","year":"2023","journal-title":"Endocr Oncol"},{"issue":"4","key":"2025100800214490200_lvaf191-B25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cen.14594","article-title":"SDHC phaeochromocytoma and paraganglioma: a UK-wide case series","volume":"96","author":"Williams","year":"2022","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2025100800214490200_lvaf191-B26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP15725.OR","article-title":"Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma\/paraganglioma: an National Institutes of Health study","volume":"22","author":"Turkova","year":"2016","journal-title":"Endocr Pract."},{"issue":"Supplement_1","key":"2025100800214490200_lvaf191-B27","doi-asserted-by":"publisher","first-page":"bvad114.143","DOI":"10.1210\/jendso\/bvad114.143","article-title":"THU613 multiple endocrine neoplasia type 5 associated with germline Max mutations\u2014new insights into this proposed entity","volume":"7","author":"Charoenngam","year":"2023","journal-title":"J Endocr Soc"},{"issue":"2","key":"2025100800214490200_lvaf191-B28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","article-title":"A roadmap to increase diversity in genomic studies","volume":"28","author":"Fatumo","year":"2022","journal-title":"Nat Med"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf191\/64304659\/lvaf191.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/4\/412\/64304659\/lvaf191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/4\/412\/64304659\/lvaf191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:21:53Z","timestamp":1759897313000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/4\/412\/8257064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf191","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,17]]}}}